Insider Selling: Organigram (TSE:OGI) Insider Sells 11,655 Shares of Stock

Organigram Holdings Inc. (TSE:OGIGet Free Report) insider Katrina May Mcfadden sold 11,655 shares of the stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of C$2.49, for a total transaction of C$29,020.95. Following the completion of the sale, the insider directly owned 30,326 shares of the company’s stock, valued at approximately C$75,511.74. This trade represents a 27.76% decrease in their position.

Katrina May Mcfadden also recently made the following trade(s):

  • On Tuesday, October 21st, Katrina May Mcfadden sold 5,135 shares of Organigram stock. The shares were sold at an average price of C$2.49, for a total transaction of C$12,786.15.
  • On Thursday, October 30th, Katrina May Mcfadden sold 8,278 shares of Organigram stock. The shares were sold at an average price of C$2.25, for a total value of C$18,625.50.

Organigram Trading Down 2.3%

OGI stock traded down C$0.05 during midday trading on Friday, hitting C$2.11. 117,363 shares of the company’s stock were exchanged, compared to its average volume of 176,953. Organigram Holdings Inc. has a 1-year low of C$1.22 and a 1-year high of C$2.89. The company has a current ratio of 3.36, a quick ratio of 2.62 and a debt-to-equity ratio of 3.07. The stock has a market capitalization of C$282.50 million, a PE ratio of 175.83, a P/E/G ratio of 0.42 and a beta of 2.16. The business has a 50-day simple moving average of C$2.43 and a two-hundred day simple moving average of C$2.11.

Organigram Company Profile

(Get Free Report)

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

Featured Articles

Insider Buying and Selling by Quarter for Organigram (TSE:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.